help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 12, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0610
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/12/4776    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nasr, C.
Right arrow Articles by Asa, S. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nasr, C.
Right arrow Articles by Asa, S. L
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Lung Cancer

Submitted on March 21, 2006
Accepted on August 31, 2006

Acromegaly and Somatotroph Hyperplasia with Adenomatous Transformation due to Pituitary Metastasis of a GHRH-Secreting Pulmonary Endocrine Carcinoma

Christian Nasr*, Alexander Mason, Marc Mayberg, Susan M Staugaitis, and Sylvia L Asa*

Department of Endocrinology and Metabolism (C.N.), Cleveland Clinic, Cleveland, OH 44195; Department of Neurological Surgery (A.M.), Cleveland Clinic, Cleveland, OH 44195; Seattle Neuroscience Institute (Executive Director) (M.M.), Seattle, Washington 98122; Departments of Neurosciences and Anatomic Pathology (S.M.S.), The Cleveland Clinic, Cleveland, OH 44195; and Department of Laboratory Medicine and Pathobiology (Pathologist-in-chief) (S.L.A.), University of Toronto, Toronto, ON M5G 2M9

* To whom correspondence should be addressed. E-mail: nasrc{at}ccf.org or Sylvia.asa{at}uhn.on.ca.

Context: GHRH excess from extracranial endocrine tumors is known to cause somatotroph hyperplasia and acromegaly. Hypothalamic gangliocytomas producing GHRH are also known to be associated with pituitary adenomas causing acromegaly.

Objectives: To describe a case of acromegaly due to a pulmonary GHRH-secreting endocrine carcinoma with metastasis to the pituitary gland and to look at the peculiar histological features of this case.

Subject: The patient was a 44-year-old woman who was diagnosed with biopsy-proven metastatic pulmonary endocrine tumor during pregnancy. Following delivery, she underwent radiation and chemotherapy for pulmonary and skeletal metastases. Her disease was clinically stable for seven years until she developed bitemporal hemianopia. She had symptoms and signs of acromegaly.

Methods: Imaging, biochemical and histological studies were performed.

Results: MRI of the brain confirmed the presence of a 2.6-cm lesion within the sella turcica extending above the sella and compressing the optic chiasm. Endocrine studies showed elevated serum levels of growth hormone, prolactin, {alpha}-subunit of glycoprotein hormones, insulin-like growth factor-1, chromogranin A and GHRH. The patient underwent uneventful transsphenoidal resection of the sellar tumor. Postoperatively, she noted an improvement in symptoms of acromegaly. Histological examination confirmed metastatic endocrine carcinoma to the pituitary, and immunohistochemistry localized GHRH to the tumor cells. The adjacent pituitary exhibited somatotroph hyperplasia with abundant reactivity for GH and {alpha}-subunit. In addition, there was focal neoplastic transformation to a sparsely granulated somatotroph phenotype with fibrous bodies.

Conclusion: This is the first report of a GHRH-producing endocrine tumor metastasizing to the pituitary and causing local hyperstimulation with somatotroph hyperplasia and adenomatous transformation.


Key words: GHRH • Acromegaly • Pituitary • Neuroendocrine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society